Nov 27, 2017New cancer treatment... using cancer survivor cells Read full article here - Note: An inaccuracy in this article is that LIfT will use survivor donor cells. We will be recruiting donors with a range of backgrounds, including specifically healthy volunteers who have no history of cancer personally or in the their family.
Read full article here - Note: An inaccuracy in this article is that LIfT will use survivor donor cells. We will be recruiting donors with a range of backgrounds, including specifically healthy volunteers who have no history of cancer personally or in the their family.
Tony De Fougerolles shares his experiences in developing industry-disrupting technologies, meeting LIfT’s CEO Alex Blyth, and his reasons for becoming Chairman of LIfT’s Board of Directors
Dr. Marco Gottardis describes his background in biopharma and why he’s excited to join LIfT as a Non-Executive Director